- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Stroke Research and Treatment
Volume 2011 (2011), Article ID 830614, 8 pages
Infection after Acute Ischemic Stroke: Risk Factors, Biomarkers, and Outcome
1Department of Neurology, Martin Luther University Halle-Wittenberg, Ernst-Grube-Strasse 40, 06120 Halle (Saale), Germany
2Department of Neurology, Klinikum Altenburger Land, Am Waldessaum 10, 04600 Altenburg, Germany
3Department of General Surgery, Klinikum Altenburger Land, Am Waldessaum 10, 04600 Altenburg, Germany
4Central Laboratory, Klinikum Altenburger Land, Am Waldessaum 10, 04600 Altenburg, Germany
5Division of Neurocritical Care, Neurological Institute, Columbia University College of Physicians and Surgeons, 710 West 168th Street, New York, NY 10032, USA
Received 22 February 2011; Accepted 31 March 2011
Academic Editor: Byung Woo Yoon
Copyright © 2011 Katja E. Wartenberg et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- K. S. Hong, D. W. Kang, J. S. Koo et al., “Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke,” European Journal of Neurology, vol. 15, no. 12, pp. 1324–1331, 2008.
- K. C. Johnston, J. Y. Li, P. D. Lyden et al., “Medical and neurological complications of ischemic stroke: experience from the ranttas trial. Ranttas investigators,” Stroke, vol. 29, no. 2, pp. 447–453, 1998.
- I. L. Katzan, R. D. Cebul, S. H. Husak, N. V. Dawson, and D. W. Baker, “The effect of pneumonia on mortality among patients hospitalized for acute stroke,” Neurology, vol. 60, no. 4, pp. 620–625, 2003.
- P. Langhorne, D. J. Stott, L. Robertson et al., “Medical complications after stroke: a multicenter study,” Stroke, vol. 31, no. 6, pp. 1223–1229, 2000.
- B. Ovbiagele, N. K. Hills, J. L. Saver, and S. C. Johnston, “Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization,” Journal of Stroke and Cerebrovascular Diseases, vol. 15, no. 5, pp. 209–213, 2006.
- D. L. Tirschwell, W. A. Kukull, and W. T. Longstreth Jr., “Medical complications of ischemic stroke and length of hospital stay: experience in Seattle, Washington,” Journal of Stroke and Cerebrovascular Diseases, vol. 8, no. 5, pp. 336–343, 1999.
- R. J. Davenport, M. S. Dennis, I. Wellwood, and C. P. Warlow, “Complications after acute stroke,” Stroke, vol. 27, no. 3, pp. 415–420, 1996.
- C. Sellars, L. Bowie, J. Bagg et al., “Risk factors for chest infection in acute stroke: a prospective cohort study,” Stroke, vol. 38, no. 8, pp. 2284–2291, 2007.
- U. Dirnagl, J. Klehmet, J. S. Braun et al., “Stroke-induced immunodepression: experimental evidence and clinical relevance,” Stroke, vol. 38, no. 2, pp. 770–773, 2007.
- A. Chamorro, X. Urra, and A. M. Planas, “Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression,” Stroke, vol. 38, no. 3, pp. 1097–1103, 2007.
- M. D. Gonsalves and Y. Sakr, “Early identification of sepsis,” Current Infectious Disease Reports, vol. 12, pp. 329–335.
- P. A. Ringleb, M. G. Bousser, G. Ford et al., “Guidelines for management of ischaemic stroke and transient ischaemic attack 2008,” Cerebrovascular Diseases, vol. 25, no. 5, pp. 457–507, 2008.
- H. P. Adams Jr., G. Del Zoppo, M. J. Alberts et al., “Guidelines for the early management of adults with ischemic stroke: a guideline from the American heart association/American stroke association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: the american academy of neurology affirms the value of this guideline as an educational tool for neurologists,” Stroke, vol. 38, no. 5, pp. 1655–1711, 2007.
- C. Cincura, O. M. Pontes-Neto, I. S. Neville et al., “Validation of the national institutes of health stroke scale, modified rankin scale and barthel index in Brazil: the role of cultural adaptation and structured interviewing,” Cerebrovascular Diseases, vol. 27, no. 2, pp. 119–122, 2009.
- A. J. Grau, F. Buggle, C. Steichen-Wiehn et al., “Clinical and biochemical analysis in infection-associated stroke,” Stroke, vol. 26, no. 9, pp. 1520–1526, 1995.
- K. G. Haeusler, W. U. Schmidt, F. Fohring et al., “Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans,” Cerebrovascular Diseases, vol. 25, no. 1-2, pp. 50–58, 2008.
- J. Klehmet, H. Harms, M. Richter et al., “Stroke-induced immunodepression and post-stroke infections: lSSessons from the preventive antibacterial therapy in stroke trial,” Neuroscience, vol. 158, no. 3, pp. 1184–1193, 2009.
- K. Prass, C. Meisel, C. Hoflich et al., “Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke t helper cell type 1-like immunostimulation,” Journal of Experimental Medicine, vol. 198, no. 5, pp. 725–736, 2003.
- A. Vogelgesang, U. Grunwald, S. Langner et al., “Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke,” Stroke, vol. 39, no. 1, pp. 237–241, 2008.
- A. Chamorro, S. Amaro, M. Vargas et al., “Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 77, no. 11, pp. 1279–1281, 2006.
- A. Hug, A. Dalpke, N. Wieczorek et al., “Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection,” Stroke, vol. 40, no. 10, pp. 3226–3232, 2009.
- J. Villar, L. Perez-Mendez, E. Espinosa et al., “Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis,” PLoS ONE, vol. 4, no. 8, article e6818, 2009.
- C. Dieler, E. Frohlich, H. Bourquain, R. Holle, and R. von Kummer, “Simple volumetry of ischemic cerebral infarction using computerized tomography.interobserver and method comparison,” Rofo, vol. 171, pp. 279–282, 1999.
- H. P. Adams Jr., B. H. Bendixen, L. J. Kappelle et al., “Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Toast. trial of org 10172 in acute stroke treatment.,” Stroke, vol. 24, no. 1, pp. 35–41, 1993.
- S. A. Schwarz, C. Sick, S. Meairs, and M. G. Hennerici, “Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: the mannheim infection in stroke study (miss),” Stroke, vol. 39, no. 4, pp. 1220–1227, 2008.
- H. P. K. Harms, C. Meisel, J. Klehmet et al., “Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial,” PLoS ONE, vol. 3, article e2158, 2008.
- A. H. J. Chamorro, V. Obach, M. Vargas et al., “The early systemic prophylaxis of infection after stroke study: a randomized clinical trial,” Stroke, vol. 36, no. 7, pp. 1495–1500, 2005.
- Y. Lampl, M. Boaz, R. Gilad et al., “Minocycline treatment in acute stroke: an open-label, evaluator-blinded study,” Neurology, vol. 69, no. 14, pp. 1404–1410, 2007.
- A. Liesz, S. Hagmann, C. Zschoche et al., “The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation,” Stroke, vol. 40, no. 8, pp. 2849–2858, 2009.
- A. Chamorro, S. Amaro, M. Vargas et al., “Catecholamines, infection, and death in acute ischemic stroke,” Journal of the Neurological Sciences, vol. 252, no. 1, pp. 29–35, 2007.
- W. F. U. Palasik, W. Lechowicz, B. Czartoryska, M. Krzesiewicz, and A. Lugowska, “Assessment of relations between clinical outcome of ischemic stroke and activity of inflammatory processes in the acute phase based on examination of selected parameters,” European Neurology, vol. 53, no. 4, pp. 188–193, 2005.
- J. Kwan and P. Hand, “Infection after acute stroke is associated with poor short-term outcome,” Acta Neurologica Scandinavica, vol. 115, no. 5, pp. 331–338, 2007.
- F. H. Vermeij, W. J. Scholte op Reimer, P. De Man, et al., “Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands stroke survey,” Cerebrovascular Diseases, vol. 27, no. 5, pp. 465–471, 2009.
- P. U. Heuschmann, P. L. Kolominsky-Rabas, B. Misselwitz et al., “Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German stroke registers study group,” Archives of Internal Medicine, vol. 164, no. 16, pp. 1761–1768, 2004.
- R. Hilker, C. Poetter, N. Findeisen et al., “Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine,” Stroke, vol. 34, no. 4, pp. 975–981, 2003.
- U. Walter, R. Knoblich, V. Steinhagen, M. Donat, R. Benecke, and A. Kloth, “Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit,” Journal of Neurology, vol. 254, no. 10, pp. 1323–1329, 2007.